Medical Health Institute scores 48/100 (grade C, ranked #529) on The Verdict Score. Here are the top-rated GLP-1 providers we'd weigh against it — same six-factor rubric, and no score is adjusted for payment.
ZipHealth is a LegitScript-certified US online doctor and pharmacy service offering injectable weight-loss treatment including compounded liraglutide via online consultation.
ZipHealth matches Medical Health Institute at 48/100; our ZipHealth ruling in full has the pricing conditions and the caveats in detail.
Basal Health is a national GLP-1 telehealth platform built around a metabolic-medicine framework, positioning GLP-1 therapy as one piece of a five-marker picture — insulin sensitivity, muscle mass, hormonal…
Basal Health scores 47/100 to Medical Health Institute's 48; our full write-up on Basal Health has the pricing conditions and the caveats in detail.
Ways2Well is a lab-based telehealth and longevity membership founded by Brigham Buhler, offering compounded GLP-1 therapy (semaglutide, with tirzepatide referenced) for weight loss alongside bloodwork,…
Ways2Well matches Medical Health Institute at 48/100; the full Ways2Well review has the pricing conditions and the caveats in detail.
HealthHub is a LegitScript-certified telehealth platform offering compounded semaglutide and tirzepatide in oral dissolving tablet (ODT) form — a rare direct-to-consumer format.
HealthHub matches Medical Health Institute at 48/100; the full HealthHub review has the pricing conditions and the caveats in detail.
PRIMO Health Partners is a telehealth practice offering virtual weight-loss consults with clinicians who prescribe GLP-1 medications, including semaglutide and tirzepatide.
PRIMO Health Partners scores 47/100 to Medical Health Institute's 48; our PRIMO Health Partners ruling in full has the pricing conditions and the caveats in detail.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Not medical advice; see our disclosure.